HIGHLIGHTS
- who: Kumiko Fujieda et al. from the Department of Nephrology, Nagoya University Hospital, Nagoya, Aichi, Japan have published the research: Assessment of Antibody-Titer Changes after Second and Third Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination in Japanese Post-Kidney-Transplant Patients, in the Journal: Vaccines 2023, 11, x FOR PEER REVIEW of 26/Oct/2022
- what: In this study, S-IgG titers were measured 5-6 months after the second vaccination and 3 weeks to 3 months after the third vaccination in post-kidney-transplant patients in Japan, and changes in the persistence . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.